Moneycontrol PRO

business

See Indian drug cos growing inorganically in 18-24 mnths:Moody's

peaking to CNBC-TV18 Kaustubh Chaubal, Vice President of the Corporate Finance Group at Moody's Investors Service said that he expects Indian generic companies to grow inorganically in the next 18-24 months. The Indian pharma companies will look at the US, Russia for inorganic growth opportunities.

first published: Dec 12, 2016 01:01 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347